DEA Prepares to Restrict Telehealth Prescribing: What It Means for Addiction Treatment Access
Leaked details reveal DEA plans to limit telehealth prescriptions for controlled substances, requiring 50% in-person visits and affecting buprenorphine access for opioid use disorder treatment.
April 23, 20264 min read